Tirzepatide is a dual GIP and GLP-1 receptor agonist used as part of comprehensive weight management strategies. It may assist with appetite regulation and metabolic optimisation when combined with appropriate lifestyle interventions.
← Weight Management & Metabolic Health
Peptide & Metabolic Therapies
Tirzepatide
Dual GIP and GLP-1 receptor agonist for comprehensive weight management
Medical supervision required: This therapy is prescription-only and provided under individual medical supervision following consultation and assessment.
Potential Applications
- Weight reduction programmes
- Appetite regulation
- Metabolic health support
- Long-term weight maintenance
The information provided on this page is intended for educational purposes only and should not be interpreted as medical advice. Individual results vary, and not all therapies are suitable for every patient. A consultation with a healthcare professional is required before commencing any treatment programme.